tiprankstipranks
Aim Immunotech Inc. (AIM)
XASE:AIM
US Market
AIM
AIM ImmunoTech
RESEARCH TOOLSreports

AIM ImmunoTech (AIM) Income Statement

968 Followers

AIM ImmunoTech Income Statement

Last quarter (Q4 2025), AIM ImmunoTech's total revenue was $21.00K, a decrease of -53.33% from the same quarter last year. In Q4, AIM ImmunoTech's net income was $-4.17M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Mar 24Mar 23Mar 22
Total Revenue
$ 88.00K$ 170.00K$ 202.00K$ 141.00K$ 135.00K
Gross Profit
$ -250.00K$ 139.00K$ 160.00K$ 565.00K$ -715.00K
Operating Expenses
$ 10.28M$ 19.91M$ 32.08M$ 20.49M$ 18.12M
Depreciation and Amortization
$ 210.00K$ 246.00K$ 238.00K$ -424.00K$ 775.00K
EBITDA
$ -10.32M$ -16.49M$ -28.72M$ -19.87M$ -18.29M
Operating Income
$ -10.53M$ -19.77M$ -31.92M$ -19.92M$ -18.84M
Other Income/Expenses
$ -3.43M$ 2.45M$ 2.95M$ 477.81K$ -289.00K
Pretax Income
$ -13.96M$ -17.32M$ -28.96M$ -19.45M$ -19.13M
Net Income
$ -13.96M$ -17.32M$ -28.96M$ -19.45M$ -19.13M
Per Share Metrics
Basic EPS
$ -8.62$ -11.22$ -21.64$ -14.69$ -14.67
Diluted EPS
$ -8.62$ -11.22$ -21.64$ -14.69$ -14.67
Weighted Average Shares Outstanding
 1.62M----
Weighted Average Shares Outstanding (Diluted)
 1.62M----
Currency in USD

AIM ImmunoTech Earnings and Revenue History